image
PDS Biotechnology Corporation PDSB
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.195
-9.16 %
$ 54.6 M
Market Cap
-1.16
P/E
BALANCE SHEET
45.4 M ASSETS
-23.63%
Growth Rates
1Year -23.63%
3Years -12.28%
5Years 25.64%
7Years -9.70%
10Years 10.28%
26.4 M LIABILITIES
-20.76%
Growth Rates
1Year -20.76%
3Years 87.66%
5Years 56.65%
7Years -1.95%
10Years -5.18%
19 B EQUITY
72629.27%
Growth Rates
1Year 72629.27%
3Years 569.92%
5Years 338.68%
7Years 126.38%
10Years 92.11%
BALANCE SHEET DECOMPOSITION
Balance Sheet PDS Biotechnology Corporation
image
Current Assets 45.1 M
Cash & Short-Term Investments 41.7 M
Receivables 0
Other Current Assets 3.36 M
Non-Current Assets 304 K
Long-Term Investments 0
PP&E 304 K
Other Non-Current Assets 0
91.91 %7.42 %Total Assets$45.4m
Current Liabilities 17.1 M
Accounts Payable 1.68 M
Short-Term Debt 12.6 M
Other Current Liabilities 2.84 M
Non-Current Liabilities 9.27 B
Long-Term Debt 9.27 M
Other Non-Current Liabilities 9.26 B
99.72 %Total Liabilities$9.3b

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 41.7 56.6 73.8 65.2 28.8 12.2 34.6 88.1 106.4 130.2 13.7 7.9 0.1
Short Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 0 0 0 0 0 0 0 0 0 0 0 0.5 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 3.4 2.5 2.7 1.6 1.5 2.3 1.0 50.9 K 0.1 1.1 1.6 0.2 6.46 K
Total Current Assets 45.1 59.1 76.5 66.8 30.3 14.5 35.7 89.1 107.4 131.3 15.4 8.5 0.1
PP&E 0.3 0.3 0.5 0.4 0.6 21.1 K 0.4 3.4 3.4 2.8 1.4 0.1 7.6 K
Intangible Assets 0 0 0 0 0 0 0 46.8 K 51.9 K 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0 0 0 0 0 0 0.1 96.1 K 91 K 55.2 K 0.2 63.9 K 8.77 K
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 45.4 59.4 77.0 67.2 30.9 14.5 36.2 92.6 110.9 134.1 17.0 8.7 0.2
LIABILITIES
Accounts Payable 1.7 7.0 1.2 1.3 1.4 1.2 0.4 4.4 3.5 2.6 2.0 1.1 0
Short Term Debt 12.6 4.2 0.3 0.3 0.1 0 0 3.1 0 (0.3) 0.3 0 0.2
Other Current Liabilities 2.8 2.4 8.3 2.2 1.7 1.6 6.0 5.4 3.2 3.7 1.6 0.7 3.3
Total Current Liabilities 17.1 13.6 9.8 3.8 3.3 2.8 6.4 12.9 6.7 8.6 3.9 1.8 3.5
Long Term Debt 9.3 19.6 23.2 0.2 0.5 0 30 K 17.4 15.0 3.0 2.5 0 27.1 K
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 9 257.3 0 0 0 0 0 0.3 0 0 0 38.5 22.3 0
Total Liabilities 26.4 33.3 33.0 4.0 3.8 2.8 6.4 30.2 21.6 11.6 44.9 24.1 3.5
EQUITY
Common Stock 12.5 K 10.9 K 9.96 K 9.39 K 7.35 K 1.74 K 10.6 K 10.4 K 9.76 K 9.72 K 770 770 770
Retained Earnings (182 111.0) (144.5) (101.6) (60.7) (43.8) (28.9) (192.8) (151.9) (101.1) (62.3) (29.8) (16.0) (8.1)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 (0.5) (0.3) (0.1) 91.4 K 38.3 K 7.05 K 0
Total Equity 19 004.8 26.1 44.0 63.2 27.1 11.7 29.8 62.4 89.3 122.5 (27.8) (15.3) (3.4)
Total Liabilities and Equity 45.4 59.4 77.0 67.2 30.9 14.5 36.2 92.6 110.9 134.1 17.0 8.7 0.2
SHARES OUTSTANDING
Common Shares Outstanding 36.5 31.0 28.6 25.6 16.7 4.9 1.6 1.5 1.4 0.4 0.8 0.8 1.4